IFNA13

Across TCGA pan-cancer cohorts, IFNA13 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated IFNA13 data layer compared with 6 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher IFNA13 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated IFNA13 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

UCEC, LUAD, and BRCA are the cancer types where IFNA13 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	All	0.396	0.722	<.001	108	view →
LUAD	OS	Tertile	All	0.363	0.691	.001	72	view →
BRCA	OS	Tertile	All	0.277	0.589	<.001	69	view →
READ	OS	Tertile	III,IV	0.287	0.748	.001	54	view →
ACC	OS	Tertile	All	0.182	0.820	<.001	45	view →
LUSC	OS	Tertile	III,IV	0.237	0.688	.014	36	view →
OV	OS	Tertile	IV	0.322	0.644	.014	18	view →
COAD	DFS	Tertile	All	0.219	0.696	.023	18	view →
THYM	OS	Tertile	II,III,IV	0.186	0.904	.025	18	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
ESCA	OS	Tertile	III,IV	0.852	0.369	.047	6	view →
THCA	OS	Tertile	All	0.762	0.958	.026	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

IFNA13–UCEC (OS)

Open the UCEC breakdown →